MicroMGx is expanding the use of its metabologenomics natural product discovery platform to mine fungi for new sustainable crop protection products at an industrial scale.
“Our platform is the first ever that can deliver new natural products at the scale required to meet that need.”
Through this expanded agreement, MicroMGx expects to support targeted natural products discovery at Corteva by applying its metabologenomics platform to accelerate the characterization of Corteva’s fungal biorepository and identify microorganisms that produce new substances with potentially new modes of action.
The unique metabologenomics platform integrates metabolomics, genomics, and bioinformatics to identify the novelty of new natural products from microbial strain collections and utilizes artificial intelligence for better precision and expedited discovery of natural products.
As part of this expanded agreement, MicroMGx technology platform will enable Corteva to identify strains of fungi that produce new and bioactive Natural Products which can be used as active ingredients for its portfolio of crop protection products.
Natural products are specialized molecules that are derived from natural sources such as plants and microorganisms, including fungi. Starting with the discovery of the first antibiotic, penicillin in 1941, many useful natural products have been discovered from fungi that have been used in pharmaceuticals and crop protection products.
This agreement builds on a 2018 agreement between MicroMGx and Corteva leveraging the MicroMGx platform, together with Corteva’s bacterial strain collection, to enable new natural products discovery.
Read full announcement here: https://www.businesswire.com/news/home/20210901005789/en/MicroMGx-Platform-to-Support-New-Study-Aimed-at-New-Natural-Product-Discovery